Bleeding in Critically Ill Children With Underlying Oncologic Diagnoses

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04170231

Enrollment

Registered

2019-11-20

Start date

2019-11-18

Completion date

2023-10-18

Last updated

2023-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bleeding, Cancer

Keywords

Critically Ill Children, 19-407

Brief summary

Bleeding in Critically Ill Children with Underlying Oncologic Diagnoses , will be a prospective observational cohort study looking at the epidemiology of bleeding in the pediatric ICU population at MSK.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

28 Days to 18 Years

Healthy volunteers

Inclusion criteria

* All children (≥28 days old through 18 years of age) with an oncologic diagnosis admitted to the PICU at Memorial Sloan Kettering Cancer Center * An oncologic diagnosis will include those with a cancer diagnosis or those being treated at MSK for blood disorders, immunodeficiencies and complications of transplant.

Exclusion criteria

* Preterm infants (\<44 weeks gestation at age of enrollment) as in these patients most bleeding etiologies are specific to the neonatal period and the bleeding assessment tool is not calibrated for this population * Known limitation of care at enrollment (standing Do Not Resuscitate order), as the interventions and clinical outcome would be biased * Pre-existing bleeding disorders

Design outcomes

Primary

Measure	Time frame
the incidence of severity of bleeding	1 year

Countries

United States

Outcome results